News & Analysis on Clinical Trial Services & Contract Research And Development
Ambit Biosciences has entered into a discovery and development collaboration with pharmaceutical company Cephalon, signifying the first time a pharma company has decided to characterise their entire library of potential drugs based on how they...
Pharma company NovaDel has announced that the US regulators have given the thumbs up to its oral spray for relieving and preventing angina due to coronary artery disease.
Drug manufacturers having troubles complying with the FDA?s current Good Manufacturing Practice (cGMP) regulations, may now have the help they need thanks to a new white paper available on the subject.
Wyeth has spent millions of dollars this week on two new deals aimed at enhancing the delivery of its drugs in development.
Tecan release their latest platform that provides reliability and flexibility for a range of 96-well format applications, including washing of ELISAs, cellular assays and protein arrays, and vacuum filtration-to-waste, such as for PCR clean up.
eClinical services provider ClinPhone has bought electronic data capture (EDC) vendor DataLabs in a bid to dominate the sector.
Running clinical trials in Eastern Europe has its pros and cons - two industry veterans from Parexel discuss how best to manage the risks.
According to a new report, drug makers are shifting to 'niche-buster' drugs in an attempt to drive future sales growth. The niche-buster drug has become a viable alternative to the blockbuster drug model that has served the industry so well.
Germany's Vetter Pharma-Fertigung has announced its plan to expand its services by adding vial filling for lyophilised - or freeze-dried - products to its portfolio.